Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
2064 | 2368 | 44.8 | 91% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
111 | 3 | THROMBOSIS RESEARCH//THROMBOSIS AND HAEMOSTASIS//HEMATOLOGY | 71244 |
2517 | 2 | PROTEASE ACTIVATED RECEPTOR//THROMBIN//THROMBIN RECEPTOR | 3827 |
2064 | 1 | PROTEASE ACTIVATED RECEPTOR//PROTEASE ACTIVATED RECEPTOR 2//THROMBIN RECEPTOR | 2368 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | PROTEASE ACTIVATED RECEPTOR | authKW | 1765041 | 10% | 56% | 246 |
2 | PROTEASE ACTIVATED RECEPTOR 2 | authKW | 762369 | 4% | 56% | 106 |
3 | THROMBIN RECEPTOR | authKW | 698554 | 4% | 53% | 102 |
4 | THROMBIN | authKW | 672219 | 19% | 11% | 455 |
5 | PROTEINASE ACTIVATED RECEPTOR | authKW | 582214 | 3% | 62% | 73 |
6 | PAR2 | authKW | 515838 | 2% | 68% | 59 |
7 | PROTEINASE ACTIVATED RECEPTOR 2 | authKW | 481974 | 2% | 69% | 54 |
8 | PAR 2 | authKW | 342540 | 2% | 45% | 59 |
9 | PROTEASE ACTIVATED RECEPTOR 2 PAR 2 | authKW | 183523 | 1% | 65% | 22 |
10 | PAR1 | authKW | 175448 | 1% | 39% | 35 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Hematology | 4391 | 14% | 0% | 325 |
2 | Peripheral Vascular Diseases | 3504 | 12% | 0% | 281 |
3 | Pharmacology & Pharmacy | 1975 | 19% | 0% | 446 |
4 | Cell Biology | 1455 | 14% | 0% | 340 |
5 | Biochemistry & Molecular Biology | 1303 | 23% | 0% | 543 |
6 | Physiology | 846 | 7% | 0% | 176 |
7 | Medicine, Research & Experimental | 358 | 6% | 0% | 136 |
8 | Chemistry, Medicinal | 308 | 4% | 0% | 98 |
9 | Immunology | 224 | 7% | 0% | 155 |
10 | Gastroenterology & Hepatology | 193 | 4% | 0% | 84 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | DIABET ENDOCRINE GRP | 97708 | 1% | 63% | 12 |
2 | MUCOSAL INFLAMMAT GRP | 80293 | 1% | 23% | 27 |
3 | ENDOCRINE GRP | 68457 | 1% | 30% | 18 |
4 | DAIICHI | 58933 | 0% | 57% | 8 |
5 | CANADIAN HLTH PROTEINASES INFLAMMAT NE | 51573 | 0% | 100% | 4 |
6 | KEY IMMUNOPHARMACOL GUANGDONG PROVINCE | 51573 | 0% | 100% | 4 |
7 | KEY IMMUNOPHARMACOL GUANGDONG PROV | 46411 | 0% | 60% | 6 |
8 | GRP PHARMACOL HEMOSTASEOL | 46044 | 0% | 71% | 5 |
9 | CENT NERVOUS SYST CARDIOVASC CHEM | 38680 | 0% | 100% | 3 |
10 | PROTEINASES INFLAMMAT NETWORK | 38680 | 0% | 100% | 3 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | BRITISH JOURNAL OF PHARMACOLOGY | 6718 | 4% | 1% | 97 |
2 | THROMBOSIS AND HAEMOSTASIS | 4117 | 2% | 1% | 57 |
3 | JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2537 | 1% | 1% | 28 |
4 | ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2178 | 2% | 0% | 36 |
5 | THROMBOSIS RESEARCH | 1756 | 2% | 0% | 38 |
6 | DRUG DEVELOPMENT RESEARCH | 1715 | 1% | 1% | 20 |
7 | JOURNAL OF BIOLOGICAL CHEMISTRY | 1607 | 6% | 0% | 146 |
8 | SEMINARS IN THROMBOSIS AND HEMOSTASIS | 1549 | 1% | 1% | 18 |
9 | JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS | 1449 | 2% | 0% | 50 |
10 | JOURNAL OF PHARMACOLOGICAL SCIENCES | 1060 | 1% | 1% | 14 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | PROTEASE ACTIVATED RECEPTOR | 1765041 | 10% | 56% | 246 | Search PROTEASE+ACTIVATED+RECEPTOR | Search PROTEASE+ACTIVATED+RECEPTOR |
2 | PROTEASE ACTIVATED RECEPTOR 2 | 762369 | 4% | 56% | 106 | Search PROTEASE+ACTIVATED+RECEPTOR+2 | Search PROTEASE+ACTIVATED+RECEPTOR+2 |
3 | THROMBIN RECEPTOR | 698554 | 4% | 53% | 102 | Search THROMBIN+RECEPTOR | Search THROMBIN+RECEPTOR |
4 | THROMBIN | 672219 | 19% | 11% | 455 | Search THROMBIN | Search THROMBIN |
5 | PROTEINASE ACTIVATED RECEPTOR | 582214 | 3% | 62% | 73 | Search PROTEINASE+ACTIVATED+RECEPTOR | Search PROTEINASE+ACTIVATED+RECEPTOR |
6 | PAR2 | 515838 | 2% | 68% | 59 | Search PAR2 | Search PAR2 |
7 | PROTEINASE ACTIVATED RECEPTOR 2 | 481974 | 2% | 69% | 54 | Search PROTEINASE+ACTIVATED+RECEPTOR+2 | Search PROTEINASE+ACTIVATED+RECEPTOR+2 |
8 | PAR 2 | 342540 | 2% | 45% | 59 | Search PAR+2 | Search PAR+2 |
9 | PROTEASE ACTIVATED RECEPTOR 2 PAR 2 | 183523 | 1% | 65% | 22 | Search PROTEASE+ACTIVATED+RECEPTOR+2+PAR+2 | Search PROTEASE+ACTIVATED+RECEPTOR+2+PAR+2 |
10 | PAR1 | 175448 | 1% | 39% | 35 | Search PAR1 | Search PAR1 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | ADAMS, MN , RAMACHANDRAN, R , YAU, MK , SUEN, JY , FAIRLIE, DP , HOLLENBERG, MD , HOOPER, JD , (2011) STRUCTURE, FUNCTION AND PATHOPHYSIOLOGY OF PROTEASE ACTIVATED RECEPTORS.PHARMACOLOGY & THERAPEUTICS. VOL. 130. ISSUE 3. P. 248 -282 | 325 | 66% | 106 |
2 | STEINHOFF, M , BUDDENKOTTE, J , SHPACOVITCH, V , RATTENHOLL, A , MOORMANN, C , VERGNOLLE, N , LUGER, TA , HOLLENBERG, MD , (2005) PROTEINASE-ACTIVATED RECEPTORS: TRANSDUCERS OF PROTEINASE-MEDIATED SIGNALING IN INFLAMMATION AND IMMUNE RESPONSE.ENDOCRINE REVIEWS. VOL. 26. ISSUE 1. P. 1-43 | 319 | 72% | 331 |
3 | MACFARLANE, SR , SEATTER, MJ , KANKE, T , HUNTER, GD , PLEVIN, R , (2001) PROTEINASE-ACTIVATED RECEPTORS.PHARMACOLOGICAL REVIEWS. VOL. 53. ISSUE 2. P. 245 -282 | 253 | 63% | 836 |
4 | OSSOVSKAYA, VS , BUNNETT, NW , (2004) PROTEASE-ACTIVATED RECEPTORS: CONTRIBUTION TO PHYSIOLOGY AND DISEASE.PHYSIOLOGICAL REVIEWS. VOL. 84. ISSUE 2. P. 579-621 | 215 | 69% | 643 |
5 | RAMACHANDRAN, R , HOLLENBERG, MD , (2008) PROTEINASES AND SIGNALLING: PATHOPHYSIOLOGICAL AND THERAPEUTIC IMPLICATIONS VIA PARS AND MORE.BRITISH JOURNAL OF PHARMACOLOGY. VOL. 153. ISSUE . P. S263 -S282 | 198 | 73% | 182 |
6 | GUTIERREZ-RODRIGUEZ, M , HERRANZ, R , (2015) FROM MULTIPLE PAR1 RECEPTOR/PROTEIN INTERACTIONS TO THEIR MULTIPLE THERAPEUTIC IMPLICATIONS.CURRENT TOPICS IN MEDICINAL CHEMISTRY. VOL. 15. ISSUE 20. P. 2080 -2114 | 240 | 59% | 3 |
7 | RAMACHANDRAN, R , NOORBAKHSH, F , DEFEA, K , HOLLENBERG, MD , (2012) TARGETING PROTEINASE-ACTIVATED RECEPTORS: THERAPEUTIC POTENTIAL AND CHALLENGES.NATURE REVIEWS DRUG DISCOVERY. VOL. 11. ISSUE 1. P. 69 -86 | 147 | 69% | 111 |
8 | BARRY, GD , LE, GT , FAIRLIE, DP , (2006) AGONISTS AND ANTAGONISTS OF PROTEASE ACTIVATED RECEPTORS (PARS).CURRENT MEDICINAL CHEMISTRY. VOL. 13. ISSUE 3. P. 243-265 | 159 | 86% | 49 |
9 | LEE, H , HAMILTON, JR , (2012) PHYSIOLOGY, PHARMACOLOGY, AND THERAPEUTIC POTENTIAL OF PROTEASE-ACTIVATED RECEPTORS IN VASCULAR DISEASE.PHARMACOLOGY & THERAPEUTICS. VOL. 134. ISSUE 2. P. 246 -259 | 149 | 76% | 19 |
10 | YAU, MK , LIU, LG , FAIRLIE, DP , (2013) TOWARD DRUGS FOR PROTEASE-ACTIVATED RECEPTOR 2 (PAR2).JOURNAL OF MEDICINAL CHEMISTRY. VOL. 56. ISSUE 19. P. 7477-7497 | 141 | 75% | 16 |
Classes with closest relation at Level 1 |